FAQ

surface enhanced laser desorption ionization

Known as: SELDI 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1981-2018
010020019812018

Related topics

Related topics

2 relations

Broader (2)

Mass SpectrometrySpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
surface enhanced laser desorption ionization
Mass Spectrometry
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Urinary protein profiling with surface-enhanced laser desorption/ionization time-of-flight mass spectrometry in ETB receptor-deficient rats.
The pathways leading to salt-sensitive hypertension and renal damage in rescued ETB receptor-deficient (ETBRd) rats are still… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
BACKGROUND Protein expression profiling for differences indicative of early cancer has promise for improving diagnostics. This… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry.
BACKGROUND Profiling approaches in proteomics, such as surface-enhanced laser desorption/ionization (SELDI) mass spectrometry… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet…
Mass spectrometry is being used to find disease-related patterns in mixtures of proteins derived from biological fluids… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification.
OBJECTIVE In order to improve the prognosis of pancreatic cancer patients, it is crucial to explore novel tools for its early… (More)
Is this relevant?
2005
2005
Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
OBJECTIVE To identify serum protein biomarkers specific for rheumatoid arthritis (RA), using surface-enhanced laser desorption… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry.
PURPOSE Each year in the United States, approximately 30,000 people die from pancreatic cancer. Fewer than 5% of patients survive… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2004
2004
Identification of novel and downregulated biomarkers for alcoholism by surface enhanced laser desorption/ionization-mass spectrometry.
Since personal and verbal reporting of alcohol use is not necessarily accurate, objective markers to assess alcohol consumption… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility.
Recent advances in proteomic profiling technologies, such as surface enhanced laser desorption ionization mass spectrometry, have… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Boosted decision tree analysis od surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.
BACKGROUND The low specificity of the prostate-specific antigen (PSA) test makes it a poor biomarker for early detection of… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?